Background: The long-term outcome in patients with chronic hepatitis C and type 2 diabetes mellitus treated with Interferon and Ribavirin is not clear. Aim: to compare the incidence of liver-related events and mortality rates between Hepatitis C Virus-positive patients with or without diabetes mellitus and the incidence of diabetes-related events between diabetic patients with and without viral infection. Methods: 309 patients with chronic hepatitis C were retrospectively included. Incidence of liver-related events, diabetes-related events and mortality rates were assessed. Results: 50 (16%) chronic hepatitis C patients had diabetes mellitus. Diabetics showed a higher number of diabetes mellitus- and liver-related events (10% vs 1.5% and 18% vs 5.7%) than non-diabetics (p=0.006, and p=0.007 respectively) with a mortality of 14% compared to 1.5% (p= 0.0003). Baseline cirrhosis (p=0.002) and non-sustained virological response ( p=0.01) were the only independent risk factors for liver events while diabetes mellitus (p=0.01) and hypertension (p=0.0017) were the only independent factors associated with diabetes-related events. Mortality and diabetes events were lower among Hepatitis C Virus-positive diabetics than among Hepatitis C Virus- negative diabetics (p=0.053, p<0.0001 respectively). Conclusions: in patients with chronic hepatitis C, diabetes mellitus was associated to a higher mortality rate and incidence of liver/diabetes-related events. However, only diabetes-related events were independently predicted by diabetes mellitus. When compared to Hepatitis C Virus-negative diabetics, those with chronic hepatitis C showed a lower mortality and a decreased incidence of diabetic complications.

Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study.

BO, Simona;SMEDILE, Antonina;CIANCIO, Alessia;BUGIANESI, Elisabetta;FAGOONEE, SHARMILA;VERSINO, Elisabetta;COSTA, Giuseppe;Sacco M;RIZZETTO, Mario;SARACCO, Giorgio Maria
2012-01-01

Abstract

Background: The long-term outcome in patients with chronic hepatitis C and type 2 diabetes mellitus treated with Interferon and Ribavirin is not clear. Aim: to compare the incidence of liver-related events and mortality rates between Hepatitis C Virus-positive patients with or without diabetes mellitus and the incidence of diabetes-related events between diabetic patients with and without viral infection. Methods: 309 patients with chronic hepatitis C were retrospectively included. Incidence of liver-related events, diabetes-related events and mortality rates were assessed. Results: 50 (16%) chronic hepatitis C patients had diabetes mellitus. Diabetics showed a higher number of diabetes mellitus- and liver-related events (10% vs 1.5% and 18% vs 5.7%) than non-diabetics (p=0.006, and p=0.007 respectively) with a mortality of 14% compared to 1.5% (p= 0.0003). Baseline cirrhosis (p=0.002) and non-sustained virological response ( p=0.01) were the only independent risk factors for liver events while diabetes mellitus (p=0.01) and hypertension (p=0.0017) were the only independent factors associated with diabetes-related events. Mortality and diabetes events were lower among Hepatitis C Virus-positive diabetics than among Hepatitis C Virus- negative diabetics (p=0.053, p<0.0001 respectively). Conclusions: in patients with chronic hepatitis C, diabetes mellitus was associated to a higher mortality rate and incidence of liver/diabetes-related events. However, only diabetes-related events were independently predicted by diabetes mellitus. When compared to Hepatitis C Virus-negative diabetics, those with chronic hepatitis C showed a lower mortality and a decreased incidence of diabetic complications.
2012
44
406
412
Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R;Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G....espandi
File in questo prodotto:
File Dimensione Formato  
articolo.pdf

Accesso riservato

Dimensione 373.4 kB
Formato Unknown
373.4 kB Unknown   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/130401
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
social impact